Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cytokine conjugation to enhance T cell therapy
Yutong Liu, Kwasi Adu‐Berchie, Joshua M. Brockman, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 120, Iss. 1
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Lyophilized lymph nodes for improved delivery of chimeric antigen receptor T cells
Jiaqi Shi, Wei Wu, Dong Chen, et al.
Nature Materials (2024) Vol. 23, Iss. 6, pp. 844-853
Closed Access | Times Cited: 22
Role and Potential of Different T Helper Cell Subsets in Adoptive Cell Therapy
David Andreu-Sanz, Sebastian Kobold
Cancers (2023) Vol. 15, Iss. 6, pp. 1650-1650
Open Access | Times Cited: 30
Engineering cells for precision drug delivery: New advances, clinical translation, and emerging strategies
Chih-Jia Chao, Endong Zhang, Zongmin Zhao
Advanced Drug Delivery Reviews (2023) Vol. 197, pp. 114840-114840
Closed Access | Times Cited: 29
Optimizing the manufacturing and antitumour response of CAR T therapy
Yutong Liu, Adam S. Sperling, Eric L. Smith, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 4, pp. 271-285
Closed Access | Times Cited: 28
Development and application of nanomaterials, nanotechnology and nanomedicine for treating hematological malignancies
Jinxin Li, Qiwei Wang, Yingli Han, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 26
CAR-T cell therapy for hematological malignancies: History, status and promise
Chao Wang, Jianpeng Wang, Shusheng Che, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21776-e21776
Open Access | Times Cited: 25
Biomaterials to enhance adoptive cell therapy
Noah Eckman, Anahita Nejatfard, Romola Cavet, et al.
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 5, pp. 408-424
Closed Access | Times Cited: 15
Cell-mediated nanoparticle delivery systems: towards precision nanomedicine
Ruoyu Cheng, Shiqi Wang
Drug Delivery and Translational Research (2024) Vol. 14, Iss. 11, pp. 3032-3054
Open Access | Times Cited: 12
CAR‐T‐cell products in solid tumors: Progress, challenges, and strategies
Kewen Qian, Guangyao Li, Shuyi Zhang, et al.
Deleted Journal (2024) Vol. 2, Iss. 2
Open Access | Times Cited: 11
Designing drug delivery systems for cell therapy
Liwen Wang, Yongsheng Gao, Zhaoqianqi Feng, et al.
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 11, pp. 944-959
Closed Access | Times Cited: 11
Strategies to Overcome Antigen Heterogeneity in CAR-T Cell Therapy
Bohan Zhang, Jiawen Wu, Hua Jiang, et al.
Cells (2025) Vol. 14, Iss. 5, pp. 320-320
Open Access | Times Cited: 1
Targeting CD8+ T cells with natural products for tumor therapy: Revealing insights into the mechanisms
Yuke Wang, Yan Zeng, Wenyong Yang, et al.
Phytomedicine (2024) Vol. 129, pp. 155608-155608
Closed Access | Times Cited: 8
Advanced micro/nano-electroporation for gene therapy: recent advances and future outlook
Feng Liu, Rongtai Su, Xinran Jiang, et al.
Nanoscale (2024) Vol. 16, Iss. 22, pp. 10500-10521
Closed Access | Times Cited: 8
Optimizing CAR-T cell therapy for solid tumors: current challenges and potential strategies
Kexin Ai, Bowen Liu, Xiaomei Chen, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 8
Advances in nano-immunotherapy for hematological malignancies
Jian Xu, Wenqi Liu, Fengjuan Fan, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Advancements in Stimulus-Responsive Co-Delivery Nanocarriers for Enhanced Cancer Immunotherapy
Meng-Ru Zhang, Linlin Fang, Yang Guo, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 3387-3404
Open Access | Times Cited: 5
T Cell Development and Function
Kwasi Adu‐Berchie, Favour O. Obuseh, David Mooney
Rejuvenation Research (2023) Vol. 26, Iss. 4, pp. 126-138
Open Access | Times Cited: 11
DNA Damage-driven Inflammatory Cytokines: Reprogramming of Tumor Immune Microenvironment and Application of Oncotherapy
Mengjie Wang, Xia Yu, Qinglei Gao
Current Medical Science (2024) Vol. 44, Iss. 2, pp. 261-272
Closed Access | Times Cited: 4
A Cytotoxic T Lymphocyte-Inspiring Microscale System for Cancer Immunotherapy
Fei Wang, Lanya Li, Xueyi Wang, et al.
ACS Nano (2025)
Closed Access
Bioinformatics identification of potential biomarkers and therapeutic targets for ischemic stroke and vascular dementia
Ding Zhang, Ni Jia, Zhihan Hu, et al.
Experimental Gerontology (2024) Vol. 187, pp. 112374-112374
Open Access | Times Cited: 3
Subtypes of tumor-associated neutrophils and their roles in cancer immunotherapy
Xinyun Chu, Ning Pu, Xue Yang, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104763-104763
Closed Access
Interfacial T cell engineering
Yunus Alapan, Susan N. Thomas
Nature Reviews Bioengineering (2025)
Closed Access
Glycopolymers With On/Off Anchors: Confinement Effect on Regulating Dendritic Cells
Xingyu Heng, Fangjian Shan, Yang He, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 28
Open Access | Times Cited: 8
Spiky Gold Nanoparticles, a Nanoscale Approach to Enhanced Ex Vivo T-Cell Activation
Fatemeh Esmaeili, Yuhao Leo Wu, Zongjie Wang, et al.
ACS Nano (2024) Vol. 18, Iss. 32, pp. 21554-21564
Closed Access | Times Cited: 3
Immunoproteasome acted as immunotherapy ‘coffee companion’ in advanced carcinoma therapy
Shaoyan Shi, Xuehai Ou, Chao Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top